Search | IOVS | ARVO Journals

Showing 1 – 20 of 36

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2020

A novel type of corneal epitheliopathy from a new class of antibody-drug conjugate anti-cancer treatments

Shahar Frenkel; ABRAHAM SOLOMON; Jacob Pe'er

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3633. doi:

ARVO Annual Meeting Abstract June 2020

Rapid onset post-operative pre-retinal fibrosis is Macular Proliferative Vitreoretinopathy (PVR) rather than Epiretinal Membrane (ERM) – A case series

Hamzah Aweidah; Samer Khateb; Shahar Frenkel; Tareq Jaouni

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):4246. doi:

ARVO Annual Meeting Abstract June 2020

Topical interferon alpha 2a for ocular surface tumors

Jacob Pe'er; Shahar Frenkel

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):4659. doi:

ARVO Annual Meeting Abstract July 2019

Treatment of vitreo-retinal lymphoma - 20 years of experience

Jacob Pe'er; Zohar Habot-Wilner; Shahar Frenkel

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2777. doi:

ARVO Annual Meeting Abstract July 2019

Infectious knockdown of CREB and HIF-1 for the treatment of metastatic uveal melanoma

Shahar Frenkel; Ana Voropaev; Maria Gimmelshein; Dudi Shneor; Alik Honigman

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):734. doi:

ARVO Annual Meeting Abstract July 2018

Frequency of atypical vascularization during IAC for retinoblastoma

Jacob Pe'er; Nadav Levinger; Jose Cohen; Shahar Frenkel

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1643. doi:

ARVO Annual Meeting Abstract July 2018

Serum exosome analysis as a predictive biomarker for metastatic uveal melanoma

Shahar Frenkel; Shahar Luski; Pratibha Gaur; Jacob Pe'er; Saray Tabak; Elie Beit-Yannai

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3186. doi:

ARVO Annual Meeting Abstract June 2017

Leaky Choroidal Nevi: A Clinical, Imaging and Therapeutic Analysis

Shahar Frenkel; Gustavo A. Gutiérrez-Vargas; Jacob Pe'er

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1787. doi:

ARVO Annual Meeting Abstract June 2017

The Use of Intravitreal Methotrexate for Treating Vitreoretinal Lymphoma

Jacob Pe'er; Ron Kaufman; Shahar Frenkel

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1800. doi:

ARVO Annual Meeting Abstract September 2016

The clinical presentation of retinoblastoma patients with mosaics

Shahar Frenkel; Jacob Pe'er

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3672. doi:

ARVO Annual Meeting Abstract September 2016

Brachytherapy with Ru-106 plaques as a primary treatment for retinoblastoma in Israel

Jacob Pe'er; Shahar Frenkel

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3679. doi:

ARVO Annual Meeting Abstract June 2015

Novel combinatorial treatment option for metastatic uveal melanoma

Shahar Frenkel; Dudi Shneor; Alik Honigman; Jacob Pe'er

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):4337. doi:

ARVO Annual Meeting Abstract April 2014

NFkB Inhibition in Uveal Melanoma - construction of a new delivery system

Shahar Frenkel; Dudi Shneor; Alik Honigman; Jacob Pe'er

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):846. doi:

ARVO Annual Meeting Abstract April 2014

sIL-2R an immuno-biomarker for prediction of metastases in uveal melanoma

Vivian Barak; Jacob Pe'er; Inna Kalickman; Shahar Frenkel

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):5076. doi:

ARVO Annual Meeting Abstract June 2013

Genetic Characterization among 232 Retinoblastoma Patients

Jacob Pe'er; Ofira Zloto; Michael Weintraub; Michal Sagi; Israela Lerer; Avishag Nadel; Ido Rot; Naomi Shoshani; Shahar Frenkel

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):3976. doi:

ARVO Annual Meeting Abstract June 2013

Targeting Uveal Melanoma Response to Hypoxia

Dudi Shneor; Alik Honigman; Jacob Pe'er; Shahar Frenkel

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):4527. doi:

ARVO Annual Meeting Abstract June 2013

NFkB Inhibition in Uveal Melanoma - Contrariety of in vitro vs. in vivo Results

Shahar Frenkel; Dudi Shneor; Jacob Pe'er; Alik Honigman

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):4529. doi:

Anatomy and Pathology/Oncology January 2013

Gender Differences in Clinical Presentation and Prognosis of Uveal Melanoma

PDF

Ofira Zloto; Jacob Pe'er; Shahar Frenkel
TAGS: gender differences, intraocular melanoma, melanoma, neoplasm metastasis, neoplasms, tumor size, mortality, patient referral
Invest. Ophthalmol. Vis. Sci.. 2013; 54(1):652-656. doi: https://doi.org/10.1167/iovs.12-10365

Anatomy and Pathology/Oncology January 2013

Insulin-Like Growth Factor-1 as a Predictive Biomarker for Metastatic Uveal Melanoma in Humans

PDF

Shahar Frenkel; Ofira Zloto; Jacob Pe'er; Vivian Barak
TAGS: biological markers, insulin-like growth factor i, intraocular melanoma, neoplasm metastasis
Invest. Ophthalmol. Vis. Sci.. 2013; 54(1):490-493. doi: https://doi.org/10.1167/iovs.12-10228

Anatomy and Pathology/Oncology October 2012

The Role of RASSF1A in Uveal Melanoma

PDF

Olga Dratviman-Storobinsky; Yoram Cohen; Shahar Frenkel; Efrat Merhavi-Shoham; Shimrit Dadon-Bar El; Natalia Binkovsky; Jacob Pe'er; Nitza Goldenberg-Cohen
TAGS: cell lines, cell transplantation, intraocular melanoma, methylation, mice, neoplasms, polymerase chain reaction, cisplatin
Invest. Ophthalmol. Vis. Sci.. 2012; 53(6):2611-2619. doi: https://doi.org/10.1167/iovs.11-7730

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

A novel type of corneal epitheliopathy from a new class of antibody-drug conjugate anti-cancer treatments

Rapid onset post-operative pre-retinal fibrosis is Macular Proliferative Vitreoretinopathy (PVR) rather than Epiretinal Membrane (ERM) – A case series

Topical interferon alpha 2a for ocular surface tumors

Treatment of vitreo-retinal lymphoma - 20 years of experience

Infectious knockdown of CREB and HIF-1 for the treatment of metastatic uveal melanoma

Frequency of atypical vascularization during IAC for retinoblastoma

Serum exosome analysis as a predictive biomarker for metastatic uveal melanoma

Leaky Choroidal Nevi: A Clinical, Imaging and Therapeutic Analysis

The Use of Intravitreal Methotrexate for Treating Vitreoretinal Lymphoma

The clinical presentation of retinoblastoma patients with mosaics

Brachytherapy with Ru-106 plaques as a primary treatment for retinoblastoma in Israel

Novel combinatorial treatment option for metastatic uveal melanoma

NFkB Inhibition in Uveal Melanoma - construction of a new delivery system

sIL-2R an immuno-biomarker for prediction of metastases in uveal melanoma

Genetic Characterization among 232 Retinoblastoma Patients

Targeting Uveal Melanoma Response to Hypoxia

NFkB Inhibition in Uveal Melanoma - Contrariety of in vitro vs. in vivo Results

Gender Differences in Clinical Presentation and Prognosis of Uveal Melanoma

Insulin-Like Growth Factor-1 as a Predictive Biomarker for Metastatic Uveal Melanoma in Humans

The Role of RASSF1A in Uveal Melanoma

To View More...

You must be signed into an individual account to use this feature.